Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 12.716 Q1 | 247 | 22 | 66 | 7351 | 1862 | 65 | 23.55 | 334.14 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.536 Q1 | 69 | 6 | 43 | 1620 | 276 | 43 | 5.82 | 270.00 | |
3 | Reviews in Contemporary Pharmacotherapy | journal | 0.261 Q3 | 18 | 6 | 79 | 1445 | 107 | 79 | 2.28 | 240.83 | |
4 | Natural Product Reports | journal | 2.341 Q1 | 200 | 34 | 115 | 7237 | 592 | 114 | 5.94 | 212.85 | |
5 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.158 Q4 | 50 | 23 | 183 | 4580 | 51 | 183 | 0.28 | 199.13 | |
6 | Progress in Medicinal Chemistry | journal | 1.288 Q1 | 37 | 8 | 19 | 1459 | 55 | 6 | 3.31 | 182.38 | |
7 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.898 Q1 | 94 | 10 | 35 | 1795 | 182 | 35 | 5.52 | 179.50 | |
8 | Pharmacology and Therapeutics | journal | 2.763 Q1 | 220 | 54 | 189 | 9653 | 1363 | 187 | 5.89 | 178.76 | |
9 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.244 Q1 | 79 | 16 | 40 | 2641 | 168 | 40 | 3.15 | 165.06 | |
10 | Studies in Natural Products Chemistry | book series | 0.337 Q3 | 45 | 24 | 76 | 3908 | 36 | 33 | 0.47 | 162.83 | |
11 | Progress in Drug Research | book series | 1.066 Q1 | 44 | 18 | 41 | 2860 | 128 | 37 | 2.11 | 158.89 | |
12 | Annual Review of Pharmacology and Toxicology | journal | 10.621 Q1 | 218 | 33 | 65 | 4729 | 1432 | 64 | 21.29 | 143.30 | |
13 | Anti-Cancer Agents in Medicinal Chemistry | journal | 103 | 18 | 0 | 2221 | 0 | 0 | 0.00 | 123.39 | ||
14 | Drug Metabolism Reviews | journal | 1.116 Q1 | 105 | 15 | 100 | 1823 | 304 | 100 | 2.99 | 121.53 | |
15 | Reviews in Toxicology | journal | 0.329 Q3 | 20 | 5 | 44 | 603 | 37 | 43 | 0.38 | 120.60 | |
16 | Expert Opinion on Therapeutic Targets | journal | 0.254 Q3 | 101 | 47 | 135 | 5636 | 70 | 135 | 0.75 | 119.91 | |
17 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 44 | 8 | 0 | 945 | 0 | 0 | 0.00 | 118.13 | ||
18 | Current Drug Targets | journal | 0.238 Q3 | 112 | 29 | 21 | 3384 | 16 | 21 | 0.76 | 116.69 | |
19 | Current Gene Therapy | journal | 78 | 24 | 0 | 2797 | 0 | 0 | 0.00 | 116.54 | ||
20 | Current Pharmaceutical Design | journal | 1.153 Q1 | 176 | 115 | 219 | 13310 | 742 | 192 | 3.17 | 115.74 | |
21 | Current Cancer Drug Targets | journal | 99 | 16 | 0 | 1772 | 0 | 0 | 0.00 | 110.75 | ||
22 | Medicinal Research Reviews | journal | 1.632 Q1 | 141 | 28 | 74 | 3075 | 382 | 73 | 5.54 | 109.82 | |
23 | CNS Drug Reviews | journal | 0.254 Q3 | 62 | 24 | 96 | 2478 | 60 | 96 | 0.61 | 103.25 | |
24 | Handbook of Analytical Separations | book series | 0.110 Q4 | 12 | 12 | 43 | 1223 | 3 | 38 | 0.07 | 101.92 | |
25 | Current Medicinal Chemistry | journal | 1.951 Q1 | 192 | 121 | 166 | 11808 | 929 | 154 | 5.79 | 97.59 | |
26 | Expert Opinion on Emerging Drugs | journal | 0.233 Q3 | 52 | 23 | 70 | 2173 | 60 | 68 | 0.89 | 94.48 | |
27 | Infectious Disorders - Drug Targets | journal | 59 | 27 | 0 | 2515 | 0 | 0 | 0.00 | 93.15 | ||
28 | Current Pharmaceutical Biotechnology | journal | 0.184 Q3 | 94 | 29 | 23 | 2659 | 17 | 23 | 0.74 | 91.69 | |
29 | Cellular and Molecular Life Sciences | journal | 2.575 Q1 | 248 | 183 | 547 | 16769 | 2342 | 533 | 4.39 | 91.63 | |
30 | Current Drug Metabolism | journal | 0.329 Q2 | 118 | 28 | 20 | 2547 | 16 | 20 | 0.80 | 90.96 | |
31 | Current Topics in Medicinal Chemistry | journal | 127 | 40 | 0 | 3529 | 0 | 0 | 0.00 | 88.23 | ||
32 | Annual Report of Shionogi Research Laboratory | journal | 0.103 Q4 | 2 | 1 | 6 | 87 | 0 | 6 | 0.00 | 87.00 | |
33 | Expert Opinion on Biological Therapy | journal | 96 | 84 | 0 | 6963 | 0 | 0 | 0.00 | 82.89 | ||
34 | Mini-Reviews in Medicinal Chemistry | journal | 101 | 38 | 0 | 3149 | 0 | 0 | 0.00 | 82.87 | ||
35 | Critical Reviews in Toxicology | journal | 2.297 Q1 | 122 | 36 | 38 | 2962 | 281 | 37 | 6.96 | 82.28 | |
36 | Advanced Drug Delivery Reviews | journal | 1.091 Q1 | 348 | 162 | 316 | 13200 | 1079 | 290 | 3.12 | 81.48 | |
37 | Drug Resistance Updates | journal | 0.727 Q1 | 125 | 42 | 155 | 3286 | 324 | 146 | 1.77 | 78.24 | |
38 | IDrugs : the investigational drugs journal | journal | 0.159 Q3 | 37 | 54 | 310 | 4189 | 71 | 306 | 0.21 | 77.57 | |
39 | Antiviral Chemistry and Chemotherapy, Supplement | journal | 12 | 17 | 0 | 1305 | 0 | 0 | 0.00 | 76.76 | ||
40 | American Journal of PharmacoGenomics | journal | 38 | 29 | 0 | 2215 | 0 | 0 | 0.00 | 76.38 | ||
41 | Drug Safety | journal | 1.019 Q1 | 136 | 86 | 238 | 6344 | 955 | 231 | 3.96 | 73.77 | |
42 | Anales de la Real Academia Nacional de Farmacia (discontinued) | journal | 0.115 Q4 | 10 | 3 | 34 | 215 | 3 | 34 | 0.04 | 71.67 | |
43 | Apoptosis : an international journal on programmed cell death | journal | 0.446 Q1 | 122 | 47 | 159 | 3353 | 143 | 159 | 0.89 | 71.34 | |
44 | Expert Opinion on Pharmacotherapy | journal | 0.301 Q3 | 88 | 168 | 105 | 11843 | 123 | 104 | 1.17 | 70.49 | |
45 | BioDrugs | journal | 0.237 Q3 | 76 | 69 | 230 | 4707 | 142 | 218 | 0.58 | 68.22 | |
46 | Side Effects of Drugs Annual | book series | 0.105 Q4 | 7 | 51 | 153 | 3328 | 6 | 153 | 0.06 | 65.25 | |
47 | Cardiovascular Drug Reviews | journal | 0.299 Q3 | 52 | 25 | 80 | 1597 | 59 | 80 | 0.52 | 63.88 | |
48 | Expert Opinion on Investigational Drugs | journal | 0.521 Q2 | 114 | 357 | 580 | 22450 | 915 | 575 | 1.72 | 62.89 | |
49 | Cutaneous and Ocular Toxicology | journal | 0.124 Q4 | 34 | 27 | 128 | 1630 | 17 | 109 | 0.10 | 60.37 | |
50 | Alkaloids: Chemical and Biological Perspectives | book series | 0.774 Q2 | 15 | 6 | 20 | 359 | 17 | 1 | 0.91 | 59.83 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®